Question:
Should people pursuing DS surgery be concerned with their stomachs stretching?
Ive read a lot about RNY postops concerns over whether their stomachs would stretch over time and allow them to eat too much. Im really confused now because this hasnt been discussed as a problem for DS patients. Since with the DS surgery your stomach starts out as 1/4 its original size (as opposed to much smaller with RNY) wouldnt that eventually stretch to twice that or more given time? Wouldnt it make sense just to leave the stomach alone and focus exclusively on the intestine? — [Anonymous] (posted on April 9, 2000)
April 9, 2000
The BPD/DS is a combination malabsorbtive and restrictive procedure, much
like the distal RNY. Increase in stomach size is a built-in feature of
<b>both</b> surgeries. In the beginning, the main reason you
lose weight is because you can't eat much, in addition to the
malabsorbtion. Over time, the amount you can eat increases, which slows
your weight loss. If you didn't have the restriction, you wouldn't lose as
much or as fast, and if the stomach didn't stretch, you wouldn't
<b>stop</b> losing. The greater malabsorbtion in the DS is
balanced by the larger stomach. The lesser malabsorbtion in the distal RNY
is balanced by the smaller stomach. You basically get to choose between
eating more and absorbing less, or eating less and absorbing more. In the
end, they both work out about the same, but the BPD/DS seems to have a
higher statistical success rate than the other surgeries. Hope this
clarifies things for you.
— Kim H.
April 10, 2000
Would you please clarify the statement "BPDS seems to have a higher
statistical success rate than the RNY" i.e. - source of info - who did
the study? Where was this published? # of study participants - etc.
— Toni B.
April 10, 2000
Toni, I'd be happy to clarify that statement. In a study entitled
"Multidisciplinary Management of Obesity", written by Mark
Bessler, MD (who is an RNY surgeon), it states: "The weight loss
associated with BPD or DS BPD is likely greater than either VBG or even GB,
although no prospective randomized trial has been published." Dr.
Bessler, with whom I've exchanged e-mail, made this statement based on
analysis of statistics provided by both RNY and DS surgeons, since no
direct comparitive study has been published (although two surgeons who
perform both the RNY and DS are preparing reports for publication, and from
what I understand, their findings support his statement). The full text of
the article has been posted here on AMOS, along with the URL for the source
information - which includes the hard data for the studies referenced.
Happy reading!
— Kim H.
April 10, 2000
Kim: I agree Dr. Bessler Report is very enlightning and the full text
warrants posting to those with slow browsers.
<p>
Multidisciplinary Management of Obesity by Mark Bessler, MD
<p>
Introduction
<p>
Obesity is now an epidemic in the United States. According to the Third
National Health and Nutrition Examination Survey, an estimated 97 million
adults in the US are either overweight or obese, and the prevalence of
obesity has increased markedly during the last decade. The combination of
historic selection for genetic traits that promote storage of fat, an
environment that has high-carbohydrate, good-tasting food readily and
constantly available, as well as an increasingly sedentary lifestyle for
many may in part explain this epidemic. Although it is estimated that 40%
to 70% of the variation in body mass and body fat is heritable,
environmental factors also determine body weight. More likely, obesity is
influenced by the interaction of genetic and environmental factors.
<p>
The National Institutes of Health defines overweight as a body mass index
(BMI) of 25.0 to 29.9 kg/m2 and obesity as a BMI of 30 kg/m2 or higher. By
this definition approximately 22% of adults in the United States are
obese.
<p>
Obesity is second only to smoking as a cause of preventable death in the
United States. Analysis of data from five prospective cohort studies and
one published study in conjunction with 1991 national statistics on BMI
distributions and overall deaths estimated that the number of annual deaths
attributed to obesity in US adults is approximately 280,000. Overweight and
obese individuals are at higher risk for developing type 2 diabetes
mellitus, hypertension, cardiovascular disease, stroke, dyslipidemia,
osteoarthritis, and some cancers. A review of the literature confirms that
weight loss may mitigate or prevent obesity-related disease.
<p>
The majority of this symposium addressed various treatment modalities used
to care for obese and especially morbidly obese subjects.
<P>
Basic Principles and Medical Management of Obesity
<p>
Samuel Klein, MD, presented the basic principles of obesity management.
Obesity is a chronic disease that requires long-term treatment. Behavioral
principles that aid patients' success in long-term life change include
small attainable goals, frequent follow-up, and a focus on the positive.
Dietary changes should include a decrease in fat as a percentage of total
calories, a decrease in total calorie intake, and an increase in fruits and
vegetables. Since dietary changes should be long-term, they must be safe
and palatable so they can be more easily maintained. Specific low-calorie
diets and even prepared liquid very low-calorie diets are often used to
obtain an initial boost in weight loss but are not proven beneficial in the
long term if not associated with lifestyle and dietary changes.
<P>
Increased exercise is critical to overall health as well as weight loss and
maintenance. A decrease in metabolic rate has been associated with weight
loss and is likely a homeostatic mechanism that exercise helps to
counteract. Thirty-five minutes of vigorous activity or 80 minutes of
moderate activity was associated with weight maintenance in a long-term
study.
<p>
Medication has a role for some obese patients, but studies have shown
moderate benefits at best and the drugs that must be taken for the expected
duration of weight loss are sometimes poorly tolerated by patients.
Phenylpropanolamine (in Dexatrim) can have adverse effects if overused.
<p>
Sibutramine (Meridia) has a CNS effect on norepinephrine and has been shown
to produce a 10% loss in body weight in 40% of patients vs an 8% body
weight loss in a placebo group. Two thirds of patients achieved 5% initial
weight loss in the treatment group. Adverse effects including tachycardia
and hypertension are not usually problematic.
<p>
Orlistat (Xenical) prevents absorption of 30% of dietary fat by blocking
lipase in the gut.
<p>
Forty percent of patients lose 10% of initial body weight in most studies,
but in diabetics only 20% of patients achieved this degree of weight loss.
Diarrhea and flatulence are frequent adverse effects but decrease within 3
to 6 months, similar to the rate of these adverse effects in control
groups.
<p>
A weight-management program combined with medication is more effective than
medication alone in most studies and consists of nutritional education,
exercise, and behavior modification.
<p>
Surgical Treatment of Obesity
<p>
Three types of surgical treatments are available that have a proven track
record of weight loss and safety. These include gastric restrictive
procedures, malabsorptive procedures, and combination procedures. In
general, purely restrictive procedures such as vertical banded gastroplasty
(VBG) have the lowest complication rates but also are associated with lower
weight loss and higher failure rates than the others. Malabsorptive
procedures such as biliopancreatic diversion (BPD) with or without duodenal
switch produce the highest weight loss and success rates but are associated
with the highest rates of metabolic complications as well as chronic
diarrhea and flatulence in some groups of patients. Gastric bypass (GB),
which combines a significant gastric restrictive component with a mild
malabsorptive component, has shown good weight loss with a very low rate of
metabolic complications. The following presentations are devoted to a
discussion of these procedures.
<p>
Morbidity of Obesity and Resolution With Surgery
<p>
Surgery for the treatment of obesity has been limited for the most part to
patients suffering from morbid obesity (MO). MO is defined as a BMI of 40
or greater and also includes patients with a BMI of 35 to 40 if associated
comorbid conditions are present that would increase the surgical benefit to
the patient. For a 5'4" woman, MO begins at just under 240 pounds. The
comorbidities of obesity are protean and the most significant and common
include diabetes, hypertension (HTN), gastroesophageal reflux disease,
sleep apnea, and osteoarthritis.
<p>
The etiology of the comorbid conditions associated with obesity is unclear.
Harvey Sugerman, MD, presented data that suggest a chronic abdominal
compartment syndrome exists in patients suffering from morbid obesity and
that this is in part responsible for many of the comorbid conditions. The
weight loss associated with GB surgery alleviates many of the comorbidities
by reducing the elevated intra-abdominal pressure in these patients.
<p>
Pickwickian syndrome, or obesity hypoventilation syndrome (OHS), is
characterized by hypoxia and hypercarbia during the day and is usually a
late manifestation of severe obesity. Sleep apnea syndrome (SAS) is
clinically suspected in obese patients who snore loudly, are tired during
the day and fall asleep frequently, or who awake tired even after adequate
length of sleep. A sleep study can confirm SAS, which should be treated
with continuous positive airway pressure or biphasic positive airway
pressure via nasal mask to decrease hypoxia at night. Sleep apnea is one of
the contributing factors to OHS.
<p>
The resolution of obesity-related problems is common after the weight loss
associated with surgery. Most patients have resolution or significant
improvement of respiratory difficulties after the weight loss associated
with GB. Eighty-five percent of noninsulin-dependent diabetes resolves and
most of the remaining patients have better control with less medication.
Improvement in hyperlipidemia and HTN is frequently seen; this is likely
the mechanism by which coronary artery disease is reduced with weight loss.
<p>
A prospective randomized study of VBG and GB reported by Dr. Sugerman
showed a better weight loss after GB and especially poor results for VBG
patients who ate sweets.
<P>
Gastroplasty and Gastric Bypass
<p>
GB and VBG are currently the two most common operations in the United
States for the treatment of MO. GB is performed more commonly. In 1967,
loop gastrojejunostomy to a transected stomach pouch was proposed by Mason,
and with the implementation of staplers in the late 1970s, this operation
began to gain acceptance. Gastroplasties initially were not successful
until reinforcement of the outlet of a vertical pouch was used in the early
1980s.
<p>
Four randomized studies comparing VBG and GB have shown improved weight
loss in the short and intermediate follow-up periods after GB. Henry
Buchwald, MD, presented retrospective data from his own institution
comparing VBG and GB, which showed increased weight loss for GB at all
times, but this was only statistically significant for women at 1 year and
the entire group at 2 years. Thereafter, no significant differences between
the two treatments were found. Dr. Sugerman questioned the poor follow-up
in this group of patients.
<p>
In choosing a surgical procedure to control MO, the following factors are
important to consider. Death and major complication rates following surgery
are approximately equal for both procedures. Operative mortality is less
than 0.5%, morbidity is approximately 5%, incisional hernia rate is
approximately 5%, and small bowel obstruction occurs in 2% of cases.
Dumping, iron deficiency, B12 deficiency, and the inability to access the
distal stomach are all problems with GB. On the other hand, while VBG does
not have these problems, it takes a long time to adjust to, the stoma
cannot be dilated, and occasionally food impaction becomes a problem. In
addition, the percentage of patients who consider the operation a failure
is likely higher after VBG than after GB.
<P>
Malabsorptive Procedures
<p>
While many surgeons are reluctant to change normal physiology in a
procedure for weight loss, malabsorptive procedures avoid severe food
restriction, which can decrease quality of life. Picard Marceau, MD,
presented the variety of procedures available in this category.
<P>
BPD is a principle that reduces the mixing of bile and pancreatic
secretions with food by diverting these secretions into the distal bowel.
The distal gastrectomy of BPD is necessary to reduce the acid production
that leads to marginal ulcer. Classic BPD often results in diarrhea,
flatulence, and a significant incidence of protein malnutrition.
<p>
Duodenal switch (DS) BPD uses a sleeve gastrectomy and keeps a portion of
the duodenal bulb with the stomach. A 250-cm alimentary limb with bile
return at 100 cm proximal to the ileocecal valve leads to significant
weight loss; diarrhea occurs in 8% and flatulence is more common. There was
not a significant discussion regarding the incidence of protein
malnutrition. Benefits of the operation include normalization of
cholesterol, triglycerides, and insulin metabolism. The weight loss
associated with BPD or DS BPD is likely greater than either VBG or even GB,
<b>although no prospective randomized trial has been
published.</b>
<p>
Protein malnutrition is a significant problem and may be more in evidence
after classic BPD than after DS BPD, relating in part to the ability to eat
protein without restriction as well as having the stomach portion of
protein digestion preserved. In part because of this serious problem as
well as the chronic diarrhea and flatulence associated with significant
protein malabsorption, the National Institutes of Health consensus
conference did not recommend BPD and suggested that most medical centers in
the United States not offer it as a primary treatment option.
<p>
<b>Complications of Bariatric Procedures</b>
<p>
Robert Brolin, MD, presented the variety of possible complications in
surgery for severe obesity. The rates of occurrence of some of these
complications are listed in Table 1. Other complications include
tachycardia (a heart rate of 120 beats per minute or higher is often the
cardinal sign), tachypnea (which may indicate the need to rule out
pulmonary embolus), fever, and abdominal tenderness.
Possible wound complications include fascial dehiscence, skin dehiscence,
infection, hernia, and seroma. Seromas should be drained early and kept
draining but do not require opening the wound.
<p>
Bleeding from ulcers or gastritis in distal stomach can be difficult to
diagnose. Direct puncture of the distal stomach may allow study. Pneumonia
is unusual and atelectasis, while frequent, is usually easily treated.
Emesis is common, but severe or intractable vomiting is rare. Often, emesis
is related to adjustment to a restrictive component and a patient eating
too much or too fast. Stomal stenosis after gastric bypass almost always
responds to balloon dilation but after VBG reoperation is frequently
necessary. Early dumping is usually not a problem because it is associated
with specific foods. Late dumping is more problematic but can be treated
with increased protein and planned carbohydrate snack 1 to 1.5 hours after
meals. Incidence of iron, B12, or folate deficiencies increases with time
and therefore iron and B12 supplements should be given. Folate can be
replaced with multivitamins. Vigilant follow-up is required indefinitely to
prevent complications from nutritional deficiency.
<P>
Preoperative and Postoperative Psychopathology
<p>
The psychopathology of preoperative and postoperative patients was
presented by Patrick O'Neil, PhD.[16] Mild to moderate obesity is not
associated with increased psychopathology. Morbid obesity in patients
seeking treatment is associated with higher lifetime prevalence of Axis I
disorders such as anxiety and depression than in the general population
(48%-57% vs 26%-35%).[16] The morbidly obese may have a higher incidence of
a history of sexual abuse and symptoms of posttraumatic stress disorder.
Impaired self-esteem is common in this population. Eating disturbances are
also common, especially binge eating, which is present in 21% of MO
patients. Bulimia and night eating syndrome are two other eating disorders
frequently seen.
<P>
Significant discrimination against people with MO is a barrier to
employment, college admission, and even medical care. Postoperative
patients report significant declines in the amount of discrimination they
experienced. Other psychosocial benefits of surgery include improvement in
body image, less binge eating, greater sense of control over eating,
decreased feelings of depression, and improved self-esteem and sense of
adequacy. Improved quality of life was dramatically documented by a study
in which many formerly obese patients stated that they would rather be
deaf, blind, or lose a limb than return to being morbidly obese.
Occasionally, however, postoperative patients may experience worsening of
relationships or difficulty dealing with other psychological stresses.
<P>
There are no known psychological predictors of good or poor weight loss
outcome and therefore treatment of an identified problem is the most
frequent action after a psychological evaluation in morbidly obese patients
seeking surgical treatment.
<p>
Laparoscopic Gastric Bypass and Laparoscopic Banding
<p>
Laparoscopic gastric bypass and laparoscopic banding are bariatric -- not
just laparoscopic -- procedures; however, they do require advanced
laparoscopic skills and should not be taken on without adequate training or
preparation. Because these operations do not cure obesity, patients require
long-term follow-up to monitor for possible metabolic complications,
according to Alan Wittgrove, MD.
<p>
Hiatal hernias, superobesity, and revisional surgery are all relative
contraindications for laparoscopic gastric bypass and laparoscopic banding,
but many of these may relate to experience and equipment issues, which will
change with time.
<p>
Laparoscopic banding with the Lap Band is currently investigational in the
United States. Weight loss is in the range of 50% of excess weight,
although early results of the US trial have not entered this range. VBG is
rarely performed laparoscopically, but a few small series have been
reported. Approximately 2000 laparoscopic GBs have been performed in the
United States with positive weight loss results. Some other benefits are
likely to be shown, especially in wound complications and recovery time.
Leak rates and stricture of the gastrojejunostomy may be more common after
the laparoscopic procedure.
<p>
The details of the operation should not be changed just to accomplish this
operation with limited access. Dr. Wittgrove's technique is very similar to
the standard open technique and results bear this out. A summary of results
shows: 75% excess weight loss with laparoscopic gastric bypass, 1
incisional hernia in 500 cases or 0.2% (not all patients were examined in
follow-up), and wound complications reported as less problematic (numbers
not presented); anastomotic leaks and stomal stenosis rates were not
discussed.
<p>
All patients should agree to laparotomy if needed, and since there is a
steep learning curve, mentoring should be considered unless advanced
laparoscopic skills are available and training has been adequate.
<p>
Plastic Surgery for Body Contouring After Weight-Loss Surgery
<P>
It is currently the standard to defer body contouring procedures such as
abdominoplasty in morbidly obese patients until after they have stabilized
their weight following weight-loss surgery.
<p>
Austin Merhof, MD, presented results of a personal series of 185
consecutive patients with body contouring after weight-loss surgery. Age
range was 23 to 70 years with a mean of 47 years, average preoperative
weight was 329 lb, with an average postoperative weight loss of 141 lb. The
interval between weight-loss surgery and body-contouring surgery was 2
years. A mean of 2.5 procedures per patient included abdominoplasty, hernia
repair, and breast, arm, and thigh reduction. Only 9 patients required
transfusion, but 43% of patients had complications, including seroma,
tissue necrosis, and infection. Previous incisions, especially a subcostal
incision, increase the incidence of flap necrosis after abdominoplasty. The
mons and suprapubic areas are especially problematic and require lowering
the inferior incision. A 2% recurrence after hernia repair sometimes
requires resection of the umbilicus; mesh was frequently used for large
defects.
<p>
Arm reduction has a low complication rate but medial excision is not as
satisfactory as posterior excision. Breast reduction is associated with a
low complication rate but specific issues with loss of tissue during weight
loss can result in difficulty obtaining good contour. Axillary excess is
dealt with as secondary procedure.
<p>
Thigh reduction is associated with the highest rate of complications,
including lymphedema, seroma, and lymphocele. Life-threatening
complications are possible and, though infrequent, must be taken into
consideration.
<p>
The Role of Liposuction in the Treatment of Obesity
<p>
Initially liposuction was not used to treat obesity, but recently many
physicians have performed large-volume liposuction. It is not yet clear if
the weight removed is ultimately regained in many or most patients. Deaths
have been reported and George Commons, MD,[19] described five guidelines
for safe surgery that have been developed: (1) a well-trained surgeon, (2)
a well-trained anesthesia team, (3) adequate facility, (4) proper patient
selection, and (5) proper medical management of the patient.
<p>
Large volume indicates aspirate of 5 liters or more; the largest volume
removed was 46 lb in three procedures. The aspirate consists of fat and
fluid, which is injected to provide vasoconstriction. Complications include
excess skin, skin loss, seroma, and infection.
<p>
Whether this weight loss will be definitive or an encouragement or initial
boost to begin a weight-loss program is still in question. Certainly this
procedure can be complementary to other weight-loss procedures. Only a
small number of patients with more than 100 lb excess weight were presented
in Dr. Commons's. Patients are encouraged to lose weight in addition to
what is removed and not to count removed weight as weight loss. Patients
who gain weight usually have it dispersed, but it can be in a limited
region, including the original liposuction site.
<p>
The technique of "superwet" (infiltration of fluid in a 1:1 ratio
with tissue to be resected) is used in large-volume resection. Keys to a
successful procedure include keeping fluid warm to maintain normal body
temperature and avoiding overwetting, which can lead to death, or
underwetting which can lead to excessive bleeding. Epinephrine and often
lidocaine are used in the wetting solution. Pressure garment should be worn
for 2 days continuously and for 2 weeks as often as possible.
<p>
The anesthesiologist does not administer much fluid to avoid overhydration.
Residual fluid should be between 90 to 120 mL/kg. A temporary decrease in
renal function is often seen and is possibly due to the epinephrine. The
use of this procedure in morbidly obese patients has not been well
evaluated and, if applicable, will likely be an adjunct to other
weight-loss procedures. Weight regained after these procedures, especially
in the morbidly obese, is not well studied but probable. The upper volume
limit that can be removed remains to be defined; the current limit is 25 lb
and only after extensive experience with lesser resection.
<p>
Truncal Circumcision
<p>
A modification of abdominoplasty, the technique of truncal circumcision was
developed to deal with additional areas of skin excess not addressed by the
classic abdominoplasty, and was discussed by Charles Horton, MD.[20] The
back, thighs, and buttocks, which are frequently problematic after
significant weight loss, are addressed by circumferential extension of the
abdominoplasty tissue excision. Increased blood loss and the need to turn
the patient to the prone position during the procedure are potential
disadvantages to truncal circumcision.
<p>
However, the benefits can be marked for the patient since
difficult-to-address skin excess in the thighs and flanks is managed in a
single procedure. Meticulous surgical technique, strong suture material in
layers, and an excision of a portion of the mons is recommended for optimal
results. Complications were described as limited. While this is a technique
that clearly requires more work and effort than standard abdominoplasty, it
appears that the advantages may render this procedure worthwhile.
<p>
It is clear from the above discussion and summary of talks that morbid
obesity is a chronic disease that is not easily treated medically. A
multidisciplinary approach to treatment with lifelong follow-up and
monitoring is necessary for successful surgical treatment, which is best
performed by a dedicated and expert team. Plastic surgery procedures can
improve the functional and cosmetic outcome of gastrointestinal weight loss
procedures and should be available for appropriate candidates.
<p>
— Victoria B.
April 10, 2000
So, 1) to clarify, there was a misquote here - Bessler did NOT say that the
"BPDS seemed to be statistically superior to the RNY" but in fact
was actually comparing the BPDS to the VGB. I think its important that we
present accurate info, as people depend on this site.
2) Anyone know anything about the eating disorder Bessler speaks of -
"Night Eating Syndrome" or where I can find more info?
— Toni B.
April 10, 2000
Toni, please allow me to clarify: 1) I never stated that the BPD was
statistically superior to the RNY, but rather said "In the end, they
both work out about the same, but the BPD/DS seems to have a higher
statistical success rate than the other surgeries." 2) Bessler
refers, in his statement, to both the VBG and the GB (gastric bypass),
which is the term he uses to describe a proximal RNY. So yes, he does state
that the BPD and BPD/DS have a higher rate of weight loss than either the
VBG or the proximal RNY. Thanks for giving me the opportunity to clear
that up!
— Kim H.
April 10, 2000
To further clarify, Dr. Bessler wrote this paper as a summary of
information presented at a 1999 bariatric surgery conference. The offer
stands for the URL which includes his reference papers, most of which have
been published in peer-reviewed journals prior to their presentation at the
conference. If anyone is interested in actually reviewing the source
information, I would be happy to provide the list of documents used to
write this paper.
— Kim H.
April 10, 2000
If anyone <b>is</b> interested in reviewing Dr. Bessler's
source material, please e-mail me. It's an extremely long list, and I
don't want to take up room here with something that may not be of interest
to more than one or two individuals.
— Kim H.
Click Here to Return